Skip to main content
MCAG
OTC Industrial Applications And Services

Annual Report Reveals Going Concern Warning, Ineffective Controls, and Nasdaq Delisting Amidst CUBEBIO Merger Plans

Analysis by Wiseek.ai
Sentiment info
Negative
Importance info
9
Price
$12.29
Mkt Cap
$35.309M
52W Low
$9.69
52W High
$12.29
Market data snapshot near publication time

summarizeSummary

Mountain Crest Acquisition Corp. V's 2025 annual report discloses a going concern warning, ineffective internal controls with prior restatements, and its delisting from Nasdaq, while confirming an ongoing business combination agreement with CUBEBIO.


check_boxKey Events

  • Going Concern Warning Issued

    Management has determined that the company's liquidity condition and mandatory liquidation, if a business combination is not consummated by November 16, 2026, raise substantial doubt about its ability to continue as a going concern.

  • Ineffective Internal Controls and Material Weaknesses

    The company's disclosure controls and procedures were deemed ineffective as of December 31, 2025. Material weaknesses in internal controls were identified due to prior restatements related to improper classification of investments and deferred underwriting fees, and errors in earnings per share.

  • Nasdaq Delisting Confirmed

    The company was delisted from Nasdaq on November 21, 2024, for failing to complete a business combination within 36 months of its IPO, and its securities now trade on the over-the-counter market.

  • Business Combination Agreement with CUBEBIO Ongoing

    The company is pursuing a business combination with CUBEBIO Co., Ltd., with stockholders having approved an extension of the combination period to November 16, 2026. The target valuation for CUBEBIO is $375,000,000.


auto_awesomeAnalysis

Mountain Crest Acquisition Corp. V's annual report for 2025 highlights significant operational and financial challenges, including a going concern warning, ineffective internal controls, and a prior delisting from Nasdaq. These issues raise substantial doubt about the company's ability to continue as a going concern, despite its ongoing efforts to complete a business combination with CUBEBIO Co., Ltd. The disclosure of material weaknesses in financial reporting, leading to restatements, further underscores the company's precarious position. Investors should be aware of the high risks associated with the company's financial stability and governance, even as it pursues a potential merger.

At the time of this filing, MCAG was trading at $12.29 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $35.3M. The 52-week trading range was $9.69 to $12.29. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed MCAG - Latest Insights

MCAG
Mar 16, 2026, 6:05 AM EDT
Source: Wiseek News
Importance Score:
7
MCAG
Mar 13, 2026, 5:33 PM EDT
Filing Type: 10-K
Importance Score:
9